BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27709233)

  • 21. Diminished circulating retinol and elevated α-TOH/retinol ratio predict an increased risk of cognitive decline in aging Chinese adults, especially in subjects with ApoE2 or ApoE4 genotype.
    Huang X; Zhang H; Zhen J; Dong S; Guo Y; Van Halm-Lutterodt N; Yuan L
    Aging (Albany NY); 2018 Dec; 10(12):4066-4083. PubMed ID: 30573705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired memory-guided attention in asymptomatic APOE4 carriers.
    Zimmermann J; Alain C; Butler C
    Sci Rep; 2019 May; 9(1):8138. PubMed ID: 31148578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele.
    West R; Beeri MS; Schmeidler J; Hannigan CM; Angelo G; Grossman HT; Rosendorff C; Silverman JM
    Am J Geriatr Psychiatry; 2008 Sep; 16(9):781-5. PubMed ID: 18757771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of apolipoprotein E4 genotype on cerebro-cerebellar connectivity, brain atrophy, and cognition in patients with Alzheimer's disease.
    de Dieu Uwisengeyimana J; Wang Y; Nguchu BA; Wang X; Qiu B
    J Neurol Sci; 2022 Nov; 442():120435. PubMed ID: 36201963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
    Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
    JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.
    Ahles TA; Li Y; McDonald BC; Schwartz GN; Kaufman PA; Tsongalis GJ; Moore JH; Saykin AJ
    Psychooncology; 2014 Dec; 23(12):1382-90. PubMed ID: 24789331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E4 Allele and Gait Performance in Mild Cognitive Impairment: Results From the Gait and Brain Study.
    Sakurai R; Montero-Odasso M
    J Gerontol A Biol Sci Med Sci; 2017 Nov; 72(12):1676-1682. PubMed ID: 28482102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E4 and sex affect neurobehavioral performance in primary school children.
    Acevedo SF; Piper BJ; Craytor MJ; Benice TS; Raber J
    Pediatr Res; 2010 Mar; 67(3):293-9. PubMed ID: 19952867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.
    Chapman BP; Benedict RHB; Lin F; Roy S; Porteinsson A; Szigeti K; Federoff H; Mapstone M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):332-339. PubMed ID: 28612377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease.
    Karim R; Koc M; Rettberg JR; Hodis HN; Henderson VW; St John JA; Allayee H; Brinton RD; Mack WJ
    Menopause; 2019 Jan; 26(1):7-15. PubMed ID: 29975287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered small-world anatomical networks in Apolipoprotein-E4 (ApoE4) carriers using MRI.
    Goryawala M; Zhou Q; Duara R; Loewenstein D; Cabrerizo M; Barker W; Adjouadi M
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2468-71. PubMed ID: 25570490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein epsilon 4 allele modifies waist-to-hip ratio effects on cognition and brain structure.
    Zade D; Beiser A; McGlinchey R; Au R; Seshadri S; Palumbo C; Wolf PA; DeCarli C; Milberg W
    J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):119-25. PubMed ID: 21835633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age.
    Kim J; Park S; Yoo H; Jang H; Kim Y; Kim KW; Jang YK; Lee JS; Kim ST; Kim S; Lee JM; Ki CS; Na DL; Seo SW; Kim HJ
    J Alzheimers Dis; 2018; 61(4):1377-1385. PubMed ID: 29376853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstructive sleep apnea and cognitive functioning in the older general population: The moderating effect of age, sex, ApoE4, and obesity.
    Marchi NA; Berger M; Solelhac G; Bayon V; Haba-Rubio J; Legault J; Thompson C; Gosselin N; Vollenweider P; Marques-Vidal P; von Gunten A; Strippoli MF; Preisig M; Draganski B; Heinzer R
    J Sleep Res; 2024 Feb; 33(1):e13938. PubMed ID: 37309703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
    Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
    Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Price of Stress: High Bedtime Salivary Cortisol Levels Are Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors. Results from the TABASCO Prospective Cohort Study.
    Tene O; Hallevi H; Korczyn AD; Shopin L; Molad J; Kirschbaum C; Bornstein NM; Shenhar-Tsarfaty S; Kliper E; Auriel E; Usher S; Stalder T; Ben Assayag E
    J Alzheimers Dis; 2018; 65(4):1365-1375. PubMed ID: 30149451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes.
    Zade D; Beiser A; McGlinchey R; Au R; Seshadri S; Palumbo C; Wolf PA; Decarli C; Milberg W
    J Stroke Cerebrovasc Dis; 2010; 19(4):261-8. PubMed ID: 20471857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. APOE ε4 Genotype and Cognitive Reserve Effects on the Cognitive Functioning of Healthy Elders.
    López ME; Turrero A; Delgado ML; Rodríguez-Rojo IC; Arrazola J; Barabash A; Maestú F; Fernández A
    Dement Geriatr Cogn Disord; 2017; 44(5-6):328-342. PubMed ID: 29414814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.